NIH-funded research P01 program project

Understanding lung vulnerability and injury in patients with IPF

Official title: Human Tissue and Cell Core

Funded at University of Colorado Denver · NIH-10815860 · Data updated 2026-11-12

This study is looking at how a protein called MUC5B affects lung health in people with idiopathic pulmonary fibrosis (IPF) by collecting and analyzing lung tissue and cells from patients to learn more about their condition and improve future treatments.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$203,901
NIH project number5P01HL162607-02
Project IDNIH-10815860 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with idiopathic pulmonary fibrosis (IPF) and healthy controls.

Less likely to help

Patients with lung conditions other than IPF or those without any lung disease may not benefit from this research.

What this research studies

This research focuses on the role of a specific protein, MUC5B, in making lungs more susceptible to injury, particularly in patients with idiopathic pulmonary fibrosis (IPF). The Human Tissue and Cell Core will collect and analyze lung tissue and cells from IPF patients to better understand their condition. By recruiting participants and carefully phenotyping their clinical and radiologic features, the research aims to gather high-quality samples that can be used for various investigations related to lung health. This centralized resource will help in isolating and storing different types of lung cells for further study.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with idiopathic pulmonary fibrosis.

How similar studies have gone: Previous research has shown promise in using human tissue and cell samples to advance understanding of lung diseases, making this approach both relevant and potentially impactful.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Yang, Ivana V — University of Colorado Denver
  • Study coordinator: Yang, Ivana V

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.